The authors Mathias Wilhelm, Tobias Schmidt and Siegfried Gessulat.
The authors Mathias Wilhelm, Tobias Schmidt and Siegfried Gessulat.
Source: A. Eckert /TUM

Machine learning makes proteomics research more effective

Using artificial intelligence, researchers at the Technical University of Munich (TUM) have succeeded in making the mass analysis of proteins from any organism significantly faster than before and almost error-free. This new approach is set to provoke a considerable change in the field of proteomics, as it can be applied in both basic and clinical research.

The genome of any organism contains the blueprints for thousands of proteins which control almost all the functions of life. Defective proteins lead to serious diseases, such as cancer, diabetes or dementia. Therefore, proteins are also the most important targets for drugs.

To better understand life processes and diseases and develop more appropriate therapies, it is necessary for as many proteins as possible to be analyzed simultaneously. At present, mass spectrometry is used in order to determine the type and quantity of proteins in a biological system. However, the current methods of data analysis continue to produce many mistakes.

A team at the Technical University of Munich led by bioinformatics scientist Mathias Wilhelm and biochemist Bernhard Küster, Professor of Proteomics and Bioanalytics at the Technical University of Munich, has now succeeded in using proteomic data to train a neural network in such a way that it is able to recognize proteins much more quickly and with almost no errors.

A solution to a serious problem

Mass spectrometers do not measure proteins directly. They analyze smaller parts consisting of amino acid sequences with up to 30 building blocks. The measured spectra of these chains are compared with databases in order to assign them to a specific protein. However, the evaluation software can only use part of the information that the spectra contain. Therefore, certain proteins are not recognized or are recognized incorrectly.

“This is a serious problem,” explains Küster. The neural network developed by the TUM team uses all the information of the spectra for the process of identification. “We miss fewer proteins and make 100 times fewer mistakes,” says Bernhard Küster.

“Prosit”, as the researchers call the AI software, is “applicable to all organisms in the world, even if their proteomes have never been examined before,” explains Mathias Wilhelm. “This enables research which was previously inconceivable.”

With the help of 100 million mass spectra, the algorithm has been so extensively trained that it can be used for all common mass spectrometers without any additional training. “Our system is the global leader in this field,” says Küster.

A market worth billions

Clinics, biotech companies, pharmaceutical companies and research institutes are using high-performance devices of this kind; the market is already worth billions. With “Prosit”, it will be possible to develop even more powerful instruments in the future. Researchers and physicians will also be better and faster able to search for biomarkers in patients’ blood or urine, or monitor therapies for their effectiveness.

The researchers also have high hopes for fundamental research. “The method can be used to track down new regulatory mechanisms in cells,” says Küster. “We hope to gain a considerable amount of knowledge here, which, in the medium and long term, will be reflected in the treatment of diseases suffered by humans, animals and plants.”

Wilhelm also expects that “AI methods such as Prosit will soon change the field of proteomics , as they can be used in almost every area of protein research”.

Subscribe to our newsletter

Related articles

Could an AI predict a healthy old age?

Could an AI predict a healthy old age?

Researchers analyze skin cells from mre than 100 people of different ages to find molecular signatures that change as people get older.

AI challenge aims to improve mammography accuracy

AI challenge aims to improve mammography accuracy

AI techniques, used in combination with the evaluation of expert radiologists, improve the accuracy in detecting cancer using mammograms.

AI finds disease-related genes

AI finds disease-related genes

An artificial neural network can reveal patterns in huge amounts of gene expression data, and discover groups of disease-related genes.

AI and laser-based imaging system identify brain tumors

AI and laser-based imaging system identify brain tumors

A novel method of combining advanced optical imaging with an artificial intelligence algorithm produces accurate, real-time intraoperative diagnosis of brain tumors.

Deep learning identifies molecular patterns of cancer

Deep learning identifies molecular patterns of cancer

An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.

Rapid test to diagnose asthma

Rapid test to diagnose asthma

Researchers use machine learning to developing a rapid test that requires only a drop of blood to diagnose asthma.

Using AI to reveal how memories are coded in the brain

Using AI to reveal how memories are coded in the brain

Researchers have discovered that a population of neurons in the brain’s frontal lobe contain stable short-term memory information within dynamically-changing neural activity.

Smart microscope adapts to diagnose infectious diseases

Smart microscope adapts to diagnose infectious diseases

Using machine learning, a prototype microscope teaches itself the best illumination settings for diagnosing malaria.

AI predicts effectiveness of immunotherapy

AI predicts effectiveness of immunotherapy

Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.

Popular articles